Recent developments in antibacterial drug discovery: microbe-derived natural products--from collection to the clinic

Expert Opinion on Investigational Drugs
Jennifer A LeedsPhilipp Krastel

Abstract

The pharmaceutical industry has historically relied on nature to provide compounds for antibacterial drug discovery. In recent years, several pharmaceutical companies have scaled back their efforts in natural product research. Nevertheless, the screening of natural products for antibacterial activity continues to provide excellent sources of biologically and chemically informative leads for new drugs. New technologies in high-throughput cultivation, genetic approaches to biodiversity and discovery of relatively untapped sources of natural products are expanding the ability to find novel, potent and highly selective antibacterial structures. Advances in purification, dereplication and structure elucidation, combined with the ability to chemically or biologically derivatise hits, aim to make the timeline for natural product-derived drug discovery similar or shorter than that expected for small synthetic molecules. This review addresses the strengths and shortcomings of technologies focused on microbe-derived natural products for antibacterial drug discovery and stresses the need for commitment to these approaches in order to achieve the goal of delivering safe, efficacious and high-quality medicines in the long run.

References

Jan 5, 1979·Journal of Molecular Biology·A L Sonenshein, H B Alexander
Jul 1, 1975·The Journal of Antibiotics·S SergioF Parenti
Jun 1, 1991·Antimicrobial Agents and Chemotherapy·R N SwansonJ J Clement
Jul 4, 1998·Natural Product Reports·I SattlerA Zeeck
Mar 29, 2001·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M TuckmanS J Projan
May 17, 2001·Antimicrobial Agents and Chemotherapy·D M LivermoreD L Shungu
Jun 9, 2001·International Journal of Antimicrobial Agents·A NostroV Alonzo
Apr 16, 2002·Molecular Microbiology·R Allyn ForsythJudith W Zyskind
May 15, 2002·Journal of Biomolecular Screening·Minna-Liisa AnköMatti Karp
May 17, 2002·The Journal of Antibiotics·Dongyu SunDavid M Rothstein
Aug 22, 2002·Journal of the American Chemical Society·Sean F BradyJon Clardy
Aug 29, 2002·Journal of the American Chemical Society·Leonard A McDonaldR Thomas Williamson
Aug 30, 2002·Applied and Environmental Microbiology·Doreen E GillespieJo Handelsman
Apr 17, 2003·Journal of Industrial Microbiology & Biotechnology·Eduardo RodriguezRobert McDaniel
Jul 10, 2003·Current Opinion in Biotechnology·Patrick D Schloss, Jo Handelsman
Oct 5, 1960·Annals of the New York Academy of Sciences·H B WOODRUFF, S A WAKSMAN
Oct 8, 2003·Current Medicinal Chemistry·Jianhua ShenHualiang Jiang
Dec 9, 2003·Applied and Environmental Microbiology·Shayne J JosephPeter H Janssen
Mar 26, 2004·Nature Reviews. Microbiology·Martin Keller, Karsten Zengler
May 11, 2004·Journal of Combinatorial Chemistry·Chuanguang QinZhihong Guo
May 13, 2004·Journal of the American Chemical Society·Stefan WeistRoderich D Süssmuth
Jun 8, 2004·Current Medicinal Chemistry·P VuorelaaH Vuorela
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Bernd HutterHannes Loferer
Jul 30, 2004·Natural Product Reports·Christoph Steinbeck
Aug 4, 2004·Methods in Enzymology·Pawan KumarYi Tang
Aug 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·K C Nicolaou, Scott A Snyder
Aug 25, 2004·The Journal of Antibiotics·Hideki HashizumeYuzuru Akamatsu
May 1, 1950·Proceedings of the National Academy of Sciences of the United States of America·M ANCHELW J ROBBINS
Sep 28, 2004·Journal of Chemical Information and Computer Sciences·Sergey G MolodtsovBrent Lefebvre
Oct 8, 2004·Nature Biotechnology·Patrick Aloy, Robert B Russell
Nov 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jörn PielShigeki Matsunaga

❮ Previous
Next ❯

Citations

Jul 31, 2008·Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes·Abdelaaty A ShahatMahmoud A Saleh
Oct 15, 2013·Journal of Computer-aided Molecular Design·Shahul H NilarThomas H Keller
Nov 23, 2007·Natural Product Reports·Dwight D BakerVineet Rajgarhia
Jan 15, 2011·Clinical Microbiology Reviews·Lynn L Silver
May 24, 2013·Marine Drugs·Marta Pelay-GimenoFernando Albericio
Jan 27, 2010·Expert Opinion on Therapeutic Patents·Renata Campos NogueiraMilena Botelho Pereira Soares
Oct 7, 2015·Journal of Industrial Microbiology & Biotechnology·Esther K SchmittP Krastel
Mar 26, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Laura Freire-MoranUNKNOWN ECDC-EMA Working Group
Nov 7, 2007·Bioorganic & Medicinal Chemistry Letters·Savvas N Georgiades, Jon Clardy
Apr 17, 2007·Trends in Microbiology·Kin S Lam
Dec 21, 2006·Journal of Clinical Pharmacy and Therapeutics·J CohenJ Sosnov
Aug 2, 2006·Angewandte Chemie·Franz von NussbaumDieter Häbich
Oct 1, 2011·Wiley Interdisciplinary Reviews. RNA·Lisa S McCoyYitzhak Tor
Apr 16, 2015·Applied Microbiology and Biotechnology·Tzi Bun NgAlaa El-Din Bekhit
Feb 7, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jack G Ganley, Emily R Derbyshire
Aug 5, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Pengcheng ZhuRongpeng Li
May 23, 2021·Briefings in Bioinformatics·Zhongqi WenJianxin Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved